Comparing adults with severe SARS-CoV-2 or influenza infection : South Africa, 2016-2021

Show simple item record

dc.contributor.author Els, Fiona
dc.contributor.author Kleynhans, Jackie
dc.contributor.author Wolter, Nicole
dc.contributor.author Du Plessis, Mignon
dc.contributor.author Moosa, Fahima
dc.contributor.author Tempia, Stefano
dc.contributor.author Makhasi, Mvuyo
dc.contributor.author Nel, Jeremy
dc.contributor.author Dawood, Halima
dc.contributor.author Meiring, Susan
dc.contributor.author Von Gottberg, Anne
dc.contributor.author Cohen, Cheryl
dc.contributor.author Walaza, sibongile
dc.date.accessioned 2024-11-27T04:43:42Z
dc.date.available 2024-11-27T04:43:42Z
dc.date.issued 2024-07-26
dc.description DATA AVAILABILITY : Data were generated at various facilities in the pneumonia surveillance programme. Derived data supporting the findings of this study are available from the corresponding author, F.E. on request. en_US
dc.description.abstract BACKGROUND : Comparisons of the characteristics of individuals hospitalised with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or seasonal influenza in low-to middleincome countries with high human immunodeficiency virus (HIV) prevalence are limited. OBJECTIVES : Determine the epidemiological differences with those hospitalised with influenza or SARS-CoV-2 infection. METHOD : We investigated hospitalised individuals ≥18 years of age testing positive for seasonal influenza (2016–2019) or SARS-CoV-2 (2020–2021). We used random effects multivariable logistic regression, controlling for clustering by site, to evaluate differences among adults hospitalised with influenza or SARS-CoV-2 infection. RESULTS : Compared to individuals with influenza, individuals with SARS-CoV-2 infection were more likely to be diabetic (adjusted odds ratio [aOR]: 1.70, 95% confidence interval [CI]: 1.11–2.61) or die in hospital (aOR: 2.57, 95% CI: 1.61–4.12). Additionally, those with SARSCoV- 2 infection were less likely to be living with HIV (not immunosuppressed) (aOR: 0.50, 95% CI: 0.34–0.73) or living with HIV (immunosuppressed) (aOR: 0.27, 95% CI: 0.18–0.39) compared to not living with HIV and less likely to be asthmatic (aOR: 0.21, 95% CI: 0.13–0.33) rather than those living with influenza. CONCLUSION : Individuals hospitalised with SARS-CoV-2 had different characteristics to individuals hospitalised with influenza before the coronavirus disease 2019 (COVID-19) pandemic. Risk factors should be considered in health management especially as we move into an era of co-circulation of SARS-CoV-2 and influenza pathogens. CONTRIBUTION : Identifying groups at high risk of severe disease could help to better monitor, prevent and control SARS-CoV-2 or influenza severe disease. en_US
dc.description.department School of Health Systems and Public Health (SHSPH) en_US
dc.description.librarian am2024 en_US
dc.description.sdg SDG-03:Good heatlh and well-being en_US
dc.description.sponsorship The Wellcome Trust; the CDC under the terms of a subcontract with the African Field Epidemiology Network (AFENET), the South African Medical Research Council (SAMRC); the African Society of Laboratory Medicine (ASLM) and Africa Centers for Disease Control and Prevention through a sub-award from the Bill and Melinda Gates Foundation; the National Institute for Communicable Diseases, a division of the National Health Laboratory Service, South Africa. en_US
dc.description.uri http://www.sajid.co.za en_US
dc.identifier.citation Els, F., Kleynhans, J., Wolter, N.. et al. Comparing adults with severe SARS-CoV-2 or influenza infection: South Africa, 2016–2021. Southern African Journal of Infectious Diseases 2024;39(1), a574. https://DOI.org/10.4102/sajid.v39i1.574. en_US
dc.identifier.issn 2312-0053 (print)
dc.identifier.issn 2313-1810 (online)
dc.identifier.other 10.4102/sajid.v39i1.574
dc.identifier.uri http://hdl.handle.net/2263/99420
dc.language.iso en en_US
dc.publisher AOSIS en_US
dc.rights © 2024. The Authors. Licensee: AOSIS. This work is licensed under the Creative Commons Attribution License. en_US
dc.subject Pneumonia surveillance en_US
dc.subject Risk factors en_US
dc.subject Severe respiratory illness en_US
dc.subject Pre-pandemic en_US
dc.subject COVID-19 pandemic en_US
dc.subject Coronavirus disease 2019 (COVID-19) en_US
dc.subject Human immunodeficiency virus (HIV) en_US
dc.subject Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) en_US
dc.subject SDG-03: Good health and well-being en_US
dc.title Comparing adults with severe SARS-CoV-2 or influenza infection : South Africa, 2016-2021 en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record